Treace Medical Q4 revenue beats estimates; sees likely revenue drop in 2026
Overview
Medical technology firm's Q4 revenue fell 9% yr/yr but beat analyst expectations
Company reported Q4 net loss of $9.4 mln, adjusted EBITDA decreased
Revenue decline due to shift towards lower-priced bunion kits
Outlook
Treace Medical expects 2026 revenue between $200 mln and $212 mln, flat to down 6% y/y
Company anticipates 2026 Adjusted EBITDA loss of $4 mln to $6 mln vs loss of $3.9 mln in 2025
Treace forecasts 50% reduction in cash usage for 2026
Result Drivers
PRODUCT MIX SHIFT - Revenue decline in Q4 2025 was primarily due to a shift towards lower-priced bunion kits
DEMAND FOR 3D SYSTEMS - Increased demand for 3D bunion correction systems drove case volume growth, per CEO John T. Treace
SURGEON BASE EXPANSION - Co increased net new active surgeons by 202, ending 2025 with 3,337 active surgeons
Company press release: ID:nGNX9FrHyR
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q4 Revenue | Beat | $62.52 mln | $61.39 mln (6 Analysts) |
Q4 EPS |
| -$0.15 |
|
Q4 Gross Margin |
| 80.60% |
|
Q4 Gross Profit |
| $50.40 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 4 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy."
Wall Street's median 12-month price target for Treace Medical Concepts Inc is $3.00, about 42.9% above its February 26 closing price of $2.10
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
Related Articles
Can Oracle Make a Strong Comeback in 2026 After Previous Struggles?
TradingKey - The focus of retail investors should be on companies with long-term revenue prospects and strong cost management. Oracle (ORCL) appears to be a good example.
The Hotter AI Gets, the More Attractive “Bricks” Become? Wall Street's HALO Craze Turns Heavy Assets Red-Hot
TradingKey - As AI technology continues to lower the barriers to replication for virtual products, global asset pricing logic is undergoing a subtle shift—tangible assets rooted in the physical world that are difficult to replace digitally are regaining significant favor from capital. This trend has
Ethereum Fails to Hit $2,200. Will ETH Hit New Lows Again in 2026?
Ethereum retreats after testing $2,200: Will it continue to drop and hit new lows?
Nvidia Q4 Earnings Beat Expectations but Stock Plunges 5.5%, $260 Billion in Market Value Erased Overnight, Why Are Investors Voting With Their Feet?
TradingKey - On February 25, 2026, global AI chip leader Nvidia (NVDA) released its fiscal 2026 fourth-quarter earnings report. Revenue, net profit, and data center business all significantly exceeded Wall Street consensus expectations, delivering a "stellar" set of results.
Deconstructing Citrini’s “2028 Global Intelligence Crisis”: S&P 8000 Bait and the Game Logic of Technological Deflation
A deep deconstruction of the 2026 AI-driven wealth migration logic, analyzing the paradox between the unemployment wave warnings and the S&P 8,000 projection in the Citrini report. Through core case studies such as Microsoft’s valuation mean reversion and Amazon AWS’s computing power dividends, this article reveals high-conviction investment opportunities in "physical layer" assets against a backdrop of technological deflation.
